Dave L Dixon Selected Research

Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)

12/2021	Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease.
8/2019	Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dave L Dixon Research Topics

Disease

23	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 01/2017
15	Heart Failure 06/2023 - 06/2016
8	Dyslipidemias (Dyslipidemia) 03/2024 - 01/2018
7	Type 2 Diabetes Mellitus (MODY) 09/2022 - 01/2018
6	Hypertension (High Blood Pressure) 01/2024 - 04/2014
5	Chronic Renal Insufficiency 02/2024 - 01/2018
5	Coronary Disease (Coronary Heart Disease) 03/2023 - 09/2014
5	Atrial Fibrillation 10/2022 - 06/2009
5	Myocardial Infarction 12/2021 - 10/2015
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2024 - 09/2014
4	COVID-19 09/2022 - 01/2021
3	Hemorrhage 12/2021 - 01/2020
3	Weight Loss (Weight Reduction) 01/2020 - 01/2018
3	Injection Site Reaction 01/2020 - 01/2019
2	Peripheral Arterial Disease 03/2024 - 07/2019
2	Chronic Disease (Chronic Diseases) 01/2023 - 10/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 01/2023
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2022 - 09/2017
2	Stroke (Strokes) 12/2021 - 01/2019
2	Obesity 08/2019 - 11/2018
2	Body Weight (Weight, Body) 01/2019 - 01/2018
1	Fibrosis (Cirrhosis) 03/2024
1	Insulin Resistance 03/2024
1	Frailty 12/2023
1	Non-alcoholic Fatty Liver Disease 11/2023
1	Aortic Diseases 11/2023
1	Acute Aortic Syndrome 11/2023
1	Hyperglycemia 07/2023
1	Neoplasms (Cancer) 07/2023
1	Cough 01/2023
1	Angioedema 01/2023
1	Pericarditis 10/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2021
1	Prediabetic State (Prediabetes) 04/2021
1	Critical Illness (Critically Ill) 01/2021
1	Hyperkalemia 01/2021

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 03/2024 - 09/2014
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2017
11	oxidized low density lipoproteinIBA 06/2024 - 09/2014
7	LDL CholesterolIBA 06/2024 - 09/2014
4	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 05/2017
4	Interleukin-1 (Interleukin 1)IBA 01/2022 - 06/2016
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2021 - 01/2021
4	Triglycerides (Triacylglycerol)IBA 10/2021 - 07/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
3	Lipoprotein(a)IBA 03/2024 - 10/2023
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 09/2017
3	C-Reactive ProteinIBA 01/2022 - 01/2016
3	evolocumabIBA 12/2021 - 01/2017
3	SodiumIBA 01/2021 - 01/2018
3	CanagliflozinIBA 01/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 03/2024 - 11/2023
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2023 - 01/2023
2	4-nitro-3-dimethylaminopropiophenoneIBA 09/2022 - 04/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2021 - 08/2019
2	alirocumabIBA 12/2021 - 01/2020
2	Proprotein Convertase 9IBA 12/2021 - 01/2020
2	Monoclonal AntibodiesIBA 12/2021 - 01/2020
2	dalcetrapibIBA 10/2021 - 05/2021
2	Fibric Acids (Fibrates)IBA 10/2021 - 05/2021
2	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2021 - 05/2021
2	HDL CholesterolIBA 10/2021 - 05/2021
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 11/2020
2	PotassiumIBA 01/2021 - 10/2015
2	CholesterolIBA 02/2020 - 03/2018
2	Vitamin K FDA Link 01/2020 - 01/2015
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020 - 10/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 10/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019 - 05/2017
2	SymportersIBA 01/2019 - 01/2018
2	Warfarin (Coumadin)FDA LinkGeneric 01/2015 - 06/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2024
1	Cholinergic Antagonists (Anticholinergics)IBA 12/2023
1	ApolipoproteinsIBA 11/2023
1	Insulin (Novolin)FDA Link 07/2023
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	CalciumIBA 03/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	EnzymesIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023
1	SolutionsIBA 01/2023
1	SubtilisinIBA 01/2023
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2023
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2023
1	BradykininIBA 01/2023
1	Colchicine FDA LinkGeneric 10/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	AntibodiesIBA 12/2021
1	Eicosapentaenoic AcidIBA 12/2021
1	Docosahexaenoic AcidsIBA 12/2021
1	Immunomodulating AgentsIBA 01/2021

Therapy/Procedure

17	Therapeutics 03/2024 - 04/2014
5	Secondary Prevention 06/2024 - 01/2015
4	Drug Therapy (Chemotherapy) 07/2023 - 07/2017
3	Glycemic Control 10/2019 - 05/2017
1	Blood Component Removal (Apheresis) 03/2024
1	Deprescriptions 12/2023